2024年11月25日，山东省正式批复，同意在济南市历下区设立省级经济开发区，定名为山东历下经济开 发区，成为济南第14家省级以上开发区。 张晓刚说，自经开区获批以来，区委、区政府高度重视经开区规划建设工作，聚焦土地性质调整、产业 规划编制等关键环节，梳理重点任务，建立工作台账，加大推进力度，加快破题起势。 齐鲁晚报·齐鲁壹点 夏侯凤超 获批复过半年，历下经济开发区（以下简称"历下经开区"）再次成为焦点。 7月8日，济南市一场新闻发布会上，历下经开区被视为历下区贯彻落实全市"工业强市"战略的核心抓 手。 半年来，历下经开区交出了怎样的答卷？有哪些新进展，又透露出哪些新信号？ 半年成绩单：从"规划蓝图"到"产业实景" "历下经济开发区是历下区贯彻落实全市工业强市战略的核心抓手。"7月8日的新闻发布会上，历下区委 常委、副区长张晓刚说。 推进和破题，首先需要高标准规划引领。 据介绍，历下经开区紧扣全市"13+34"产业链体系，锚定"X+2"主导产业定位，确定现代医药、电子信 息两大主导产业，聚焦细胞与基因治疗、高端软件两大特色方向，前瞻布局脑机接口、智能机器人、生 成式人工智能等未来产业，着力打造现代化科创高地。 ...

Group 1 - The 42nd National Pharmaceutical Industry Information Annual Conference and the 2025 Beijing-Changping Life Science Forum opened, focusing on the layout of pharmaceutical research and the transformation of original achievements, with 14 major pharmaceutical health industry projects signed in Changping District [1] - Major projects include investments from companies such as Mindray Medical, Diyi Group, Yourui Bio, and others, as well as innovative collaborations with institutions like Shantou University and the National Research Institute of High-Performance Medical Devices [1][2] - The Beijing Future Pharmaceutical Industry Chain Research Institute was unveiled, aiming to support key technology collaboration and promote international development of the pharmaceutical industry [1] Group 2 - A joint initiative was launched among Tsinghua University, Peking University, China Agricultural University, and Beijing University of Chemical Technology to drive breakthroughs in biomedicine and synthetic biology, enhancing China's position in the global pharmaceutical value chain [2] - The "Support Measures for the Development of the Pharmaceutical Health Industry in the Changping Group of the China (Beijing) Free Trade Pilot Zone" were announced, focusing on cross-border R&D cooperation and aligning with international standards [2] - Changping District has established a complete industrial chain from basic research to terminal medical services, with an average annual growth rate of 9.3% in pharmaceutical health industry revenue over the past three years, projected to reach 104 billion yuan in 2024, a year-on-year increase of 14.3% [2][3] Group 3 - The district has seen continuous innovation, with four key technologies selected as major scientific achievements for the 2025 Zhongguancun Forum, and 27 cell and gene therapy pipelines entering clinical stages, accounting for 5% of the national total [3] - The Zhongguancun synthetic biology manufacturing industry cluster has attracted 121 innovative enterprises, and the "Future City" health industry has formed a 10 billion yuan cluster [3] - Changping District aims to enhance the ecosystem of industrial elements and improve service quality, striving to make the Life Science Park a globally competitive hub for the pharmaceutical health industry [3]